LOS ANGELES--(BUSINESS WIRE)-- MedMen Enterprises Inc. (“MedMen” or the “Company”) (CSE: MMEN) (OTCQX: MMNFF) plans to release its financial results for the first quarter fiscal 2020 ended September 28, 2019 after market close on Tuesday, November 26, 2019.

Following the release of these financial results, at 5:00 PM Eastern that same day, MedMen Enterprises will host a conference call and audio webcast with Chief Executive Officer and Co-Founder, Adam Bierman, and Chief Financial Officer, Zeeshan Hyder, to discuss the results in further detail.

Webcast Information:

A live audio webcast of the call will be available on the Events and Presentations section of MedMen’s website at: https://investors.medmen.com/events-and-presentations/default.aspx and will be archived for replay.

Calling Information:

Toll Free Dial-In Number: (844) 559-7829

International Dial-In Number: (647) 689-5387

Conference ID: 7253627

ABOUT MEDMEN:

Founded in 2010, MedMen is North America’s premium cannabis retailer. Founders Adam Bierman and Andrew Modlin have defined the next generation discovery platform for cannabis and all its benefits. A robust selection of high-quality products, including MedMen-owned brands [statemade], LuxLyte and MedMen Red, coupled with a team of cannabis-educated associates cement the Company’s commitment to providing an unparalleled experience. MedMen’s industry-leading technology enables a fully compliant, owned-and-operated delivery service and MedMen Buds, a nationwide loyalty program. MedMen believes that a world where cannabis is legal and regulated is safer, healthier and happier. Learn more at www.MedMen.com.

SOURCE: MedMen Enterprises

View source version on businesswire.com: https://www.businesswire.com/news/home/20191030005365/en/

OFFICER CONTACT:

Adam Bierman

Chief Executive Officer

info@medmen.com

855-292-8399

MEDIA CONTACT:

Christian Langbein

Vice President, Communications

communications@medmen.com

424-320-2367

INVESTOR RELATIONS CONTACT:

Stéphanie Van Hassel

Vice President, Investor Relations

investors@medmen.com

(323) 705-3025

Source: MedMen Enterprises